John Bourke

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri et al. · The Lancet · 2011 · 862 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Importance of lead selection in QT interval measurement

J C Cowan, K. Yusoff, Malcolm A.S. Moore et al. · The American Journal of Cardiology · 1988 · 341 citations

Engineering, Electrical Engineering, Instrumentation +3

Managing Duchenne muscular dystrophy – The additive effect of spinal surgery and home nocturnal ventilation in improving survival

Michelle Eagle, John Bourke, R. Bullock et al. · Neuromuscular Disorders · 2007 · 336 citations

Medicine, Neurology, Surgery +12

107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands

Kate Bushby, Francesco Muntoni, John Bourke · Neuromuscular Disorders · 2003 · 305 citations

Medicine, Cardiology, Internal Medicine +16

The phenotype of limb-girdle muscular dystrophy type 2I

Maja Poppe, Lynsey Cree, John Bourke et al. · Neurology · 2003 · 196 citations

Medicine, Genetics, Neurology +10